Associations of plasma hepcidin with mortality risk in patients with coronary artery disease-Reference-Cited by-同舟云学术

Associations of plasma hepcidin with mortality risk in patients with coronary artery disease

Published:2017-11-27 Issue:65 Volume:8 Page:109497-109508
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Li Xinrui¹,Ding Ding¹,Zhang Yuan²,Su Dongfang¹,Wang Min¹,Chen Xuechen¹,Yang Yan¹,Hong Changjiang²,Hu Gang³,Ling Wenhua¹

Affiliation:

1. Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, China

2. Department of Cardiology, General Hospital of Guangzhou Military Command of People’s Liberation Army, Guangzhou, Guangdong, China

3. Chronic Disease Epidemiology Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study;Cardiovascular Diabetology;2024-08-17

2. Elevated Hepcidin Expression in Human Carotid Atheroma: Sex-Specific Differences and Associations with Plaque Vulnerability;International Journal of Molecular Sciences;2024-01-30

3. Regarding the paradox of increased coronary atherosclerosis among highly trained athletes: Might hepcidin be the culprit?;Medical Hypotheses;2024-01

4. Association of hepcidin with serum lipids, triglyceride-glucose index, and High-sensitivity cardiac troponin T in Metabolic syndrome population;2023-08-24

5. Iron Metabolism Markers and Lower Extremity Arterial Disease in People with Type 2 Diabetes;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-10